iPSC Technology — The Science of Beginning Again

The 2012 Nobel Prize-winning discovery that changed regenerative medicine forever. Understanding why our exosome source makes all the difference.

🏆

Nobel Prize in Physiology or Medicine, 2012

Awarded to Shinya Yamanaka and John B. Gurdon for the discovery that mature, specialised cells can be reprogrammed to become pluripotent — the foundational science behind iPSC technology and our exosome source.

The Science of Cellular Reprogramming

Every cell in your body — whether a skin cell, liver cell, or neuron — contains the same complete DNA. What makes each cell type different is which genes are switched on. In 2006, Yamanaka discovered that by introducing just four transcription factors (now called Yamanaka factors: Oct4, Sox2, Klf4, c-Myc), any adult specialised cell could be reprogrammed back to a pluripotent state — essentially becoming a stem cell again.

These reprogrammed cells are called Induced Pluripotent Stem Cells (iPSC). From this pluripotent state, they can theoretically become any cell type in the body — and critically, they secrete exosomes carrying the biological signature of youth and unlimited regenerative potential.

🔄

Reprogramming

Adult specialised cells are reprogrammed using Yamanaka factors back to a pluripotent ground state.

🌱

Pluripotency

iPSC cells regain the biological youth and unlimited differentiation potential of embryonic stem cells.

📦

Exosome Harvest

iPSC cultures secrete exosomes richly loaded with pluripotent regenerative signals — the most potent available.

🏭

GMP Production

Exosomes are purified and concentrated in our GMP-certified partner facility in Taipei, Taiwan.

Taiwan's GMP-Certified Research Excellence

Our iPSC exosomes are produced by a leading biotechnology research university in Taipei, Taiwan — a globally recognised centre of stem cell science excellence. The facility operates under Good Manufacturing Practice (GMP) standards, the highest pharmaceutical manufacturing standard globally.

GMPPharmaceutical Grade
ISOQuality Management
NTAParticle Characterised
5B+Particles per Vial

Every batch is tested for: particle size distribution (NTA), protein marker expression (CD9, CD63, CD81), sterility, mycoplasma, endotoxin levels, and particle concentration before release. Full certificate of analysis available for clinic partners.

Why Our Exosomes Are Different

  • Sourced from a standardised, validated iPSC cell line — not variable donor adult cells
  • Rich in pluripotency-associated signals: Oct4, Sox2, Nanog pathway exosomes
  • Consistent particle count across every batch (NTA verified)
  • Full cold-chain delivery from Taipei to Malaysia
  • Clinic training and protocol support included
  • Research collaboration available for academic partners

The Most Advanced Exosome Science, Available in Malaysia

Partner with us or find a clinic near you.

For Clinics & Doctors Clinical Evidence